BioSpace News Archive

Scannable cast codes prove successful in proactive management of potential cast problems [21-May-2020] ROSEMONT, Ill. , May 21, 2020 /PRNewswire/ -- When children require a cast due to a bone fracture, follow-up care instructions are typically given verbally or the patient is sent home with written instructions. However, patients and their caregivers run the risk of f

Nephron Pharmaceuticals Corporation, one of the fastest growing pharmaceutical companies in the country, today announced a new partnership with One Medical, a leading national digital health and primary care organization that combines 24/7 access to virtual care and digital health tools with COVID-19 testing services to businesses and employees.

Wolters Kluwer, Health , a leading global provider of information and point of care solutions for the healthcare industry, has entered into a multi-year agreement with the American Society of Clinical Oncology, Inc. (ASCO ® ), the world’s leading organization of its kind representing nearly 45,000 oncology professionals who care for people with cancer. Under this agreement, beginning in January 2021, Wolters Kluwer wil

FlowMetric Diagnostics, Inc., a division of FlowMetric Life Sciences, Inc. focused on providing immune monitoring testing, announces the expansion of their testing services to include validated serological antibody testing for SARS-CoV-2 (COVID-19) exposure.

OrthogenRx, Inc., a medical device company focused on the development and commercialization of treatments for knee pain caused by osteoarthritis (OA), today announced that “The Journal of Bone and Joint Surgery (JBJS)” has published a response in the journal’s Orthopaedic Forum,

Aran Biomedical Teoranta, provider of outsourced design, development and manufacturing services for implantable devices, today announced the availability of its ProTEX Med® implantable grade material for purchase as a standalone raw material for products requiring implant grade polypropylene (PP).

Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where the complement (C5) and/or leukotriene (LTB4) systems are implicated, today announced that the European Medicines Agency

New Multi-year Public Health Campaign and Documentary Focus on Mental Health Issues

Komodo Health today announced it has renewed its certification in the Centers for Medicare and Medicaid Services (CMS) Qualified Entity (QE) Program, also known as the Medicare Data Sharing for Performance Measurement Program. Komodo Health has been a certified QE since August 2017, enabling the company to offer the mo

Hand hygiene management system protects against the threat and spread of illness with a hand scanner that tracks handwashing frequency and effectiveness